{"id":"https://openalex.org/W2602803086","doi":"https://doi.org/10.1200/jco.2014.32.15_suppl.1035","title":"Final results of a phase 2 study of ramucirumab (RAM) plus eribulin (E) versus E in advanced metastatic breast cancer (MBC).","display_name":"Final results of a phase 2 study of ramucirumab (RAM) plus eribulin (E) versus E in advanced metastatic breast cancer (MBC).","publication_year":2014,"publication_date":"2014-05-20","ids":{"openalex":"https://openalex.org/W2602803086","doi":"https://doi.org/10.1200/jco.2014.32.15_suppl.1035","mag":"2602803086"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2014.32.15_suppl.1035","doi":"https://doi.org/10.1200/jco.2014.32.15_suppl.1035","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2014.32.15_suppl.1035","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5022422153","display_name":"Denise Aysel Yardley","orcid":"https://orcid.org/0000-0002-8664-3458","observed_orcids":["https://orcid.org/0000-0002-8664-3458","https://orcid.org/0009-0008-1720-6183"]},"institutions":[{"id":"https://openalex.org/I4210100810","display_name":"Sarah Cannon","ror":"https://ror.org/014t21j89","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210100810"]},{"id":"https://openalex.org/I4210135086","display_name":"Tennessee Oncology","ror":"https://ror.org/03754ky26","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210135086"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Denise A. Yardley","raw_affiliation_strings":["Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville, TN","institution_ids":["https://openalex.org/I4210100810","https://openalex.org/I4210135086"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017228186","display_name":"Paul D. Richards","orcid":"https://orcid.org/0000-0002-0320-9083","observed_orcids":["https://orcid.org/0000-0002-0320-9083"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paul D. Richards","raw_affiliation_strings":["Oncology and Hematology Associates of Southwest Virginia, Salem, VA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology and Hematology Associates of Southwest Virginia, Salem, VA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063636021","display_name":"James Andrew Reeves","orcid":"https://orcid.org/0000-0001-9690-7341","observed_orcids":["https://orcid.org/0000-0001-9690-7341"]},"institutions":[{"id":"https://openalex.org/I4210118420","display_name":"Florida Cancer Specialists & Research Institute","ror":"https://ror.org/02px37122","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210118420"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James Andrew Reeves","raw_affiliation_strings":["Florida Cancer Specialists, Fort Myers, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Florida Cancer Specialists, Fort Myers, FL","institution_ids":["https://openalex.org/I4210118420"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016973435","display_name":"Elizabeth Claire Dees","orcid":"https://orcid.org/0000-0003-4004-7316","observed_orcids":["https://orcid.org/0000-0003-4004-7316"]},"institutions":[{"id":"https://openalex.org/I4390039329","display_name":"UNC Lineberger Comprehensive Cancer Center","ror":"https://ror.org/043ehm030","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elizabeth Claire Dees","raw_affiliation_strings":["UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC","institution_ids":["https://openalex.org/I4390039329"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079509906","display_name":"Cynthia R. C. Osborne","orcid":"https://orcid.org/0000-0001-8040-4985","observed_orcids":["https://orcid.org/0000-0001-8040-4985"]},"institutions":[{"id":"https://openalex.org/I2802366037","display_name":"Baylor University Medical Center","ror":"https://ror.org/03nxfhe13","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2802366037","https://openalex.org/I4210160418"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cynthia R. C. Osborne","raw_affiliation_strings":["Baylor Charles A. Sammons Cancer Center, Dallas, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Baylor Charles A. Sammons Cancer Center, Dallas, TX","institution_ids":["https://openalex.org/I2802366037"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090789911","display_name":"Hatem Hussein Soliman","orcid":"https://orcid.org/0000-0001-6644-2264","observed_orcids":["https://orcid.org/0000-0001-6644-2264"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hatem Hussein Soliman","raw_affiliation_strings":["H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015942645","display_name":"Devchand Paul","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140702","display_name":"Rocky Mountain Cancer Centers","ror":"https://ror.org/03ynhs115","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210140702"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Devchand Paul","raw_affiliation_strings":["Rocky Mountain Cancer Centers, Denver, CO"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rocky Mountain Cancer Centers, Denver, CO","institution_ids":["https://openalex.org/I4210140702"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059723987","display_name":"Foluso Olabisi Ademuyiwa","orcid":"https://orcid.org/0000-0002-6766-2258","observed_orcids":["https://orcid.org/0000-0002-6766-2258"]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Foluso Olabisi Ademuyiwa","raw_affiliation_strings":["Washington University School of Medicine in St. Louis, St. Louis, MO"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Washington University School of Medicine in St. Louis, St. Louis, MO","institution_ids":["https://openalex.org/I204465549"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031957382","display_name":"Troy H. Guthrie","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210095251","display_name":"Baptist Cancer Center","ror":"https://ror.org/00skc2q21","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210095251"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Troy H. Guthrie","raw_affiliation_strings":["Baptist Cancer Institute, Jacksonville, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Baptist Cancer Institute, Jacksonville, FL","institution_ids":["https://openalex.org/I4210095251"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000035636","display_name":"Jane L. Bromund","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jane L. Bromund","raw_affiliation_strings":["Eli Lilly and Company, Indianapolis, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Indianapolis, IN","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113782564","display_name":"Yihuan Xu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yihuan Xu","raw_affiliation_strings":["ImClone Systems, a wholly-owned subsidiary of Eli Lilly & Co, Bridgewater, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ImClone Systems, a wholly-owned subsidiary of Eli Lilly & Co, Bridgewater, NJ","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112266428","display_name":"Ayman B. Ibrahim","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ayman B. Ibrahim","raw_affiliation_strings":["ImClone Systems Corporation, a wholly owned subsidiary of Eli Lilly and Company, Bridgewater, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ImClone Systems Corporation, a wholly owned subsidiary of Eli Lilly and Company, Bridgewater, NJ","institution_ids":["https://openalex.org/I168537998"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":10,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":16,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"32","issue":"15_suppl","first_page":"1035","last_page":"1035"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.8237000107765198,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.8237000107765198,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.0934000015258789,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.049300000071525574,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ramucirumab","display_name":"ramucirumab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/eribulin","display_name":"eribulin","score":1.0},{"id":"https://openalex.org/keywords/vegfr-2-inhibition","display_name":"VEGFR-2 inhibition","score":0.8949999809265137},{"id":"https://openalex.org/keywords/microtubule-inhibitors","display_name":"microtubule inhibitors","score":0.8029999732971191},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.8619999885559082},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.8980000019073486},{"id":"https://openalex.org/keywords/third-line-therapy","display_name":"third-line therapy","score":0.7009999752044678},{"id":"https://openalex.org/keywords/anti-angiogenic-therapy","display_name":"anti-angiogenic therapy","score":0.6389999985694885},{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.7540000081062317},{"id":"https://openalex.org/keywords/hemorrhage","display_name":"hemorrhage","score":0.38999998569488525},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.8460000157356262},{"id":"https://openalex.org/keywords/congestive-heart-failure","display_name":"congestive heart failure","score":0.7789999842643738},{"id":"https://openalex.org/keywords/treatment-emergent-adverse-events","display_name":"treatment-emergent adverse events","score":0.6940000057220459},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.38100001215934753},{"id":"https://openalex.org/keywords/objective-response-rate","display_name":"objective response rate","score":0.6290000081062317},{"id":"https://openalex.org/keywords/dose-intensity","display_name":"dose intensity","score":0.625},{"id":"https://openalex.org/keywords/brain-metastases","display_name":"brain metastases","score":0.5580000281333923}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8869019746780396},{"id":"https://openalex.org/C2776387010","wikidata":"https://www.wikidata.org/wiki/Q408717","display_name":"Eribulin","level":5,"score":0.7973628640174866},{"id":"https://openalex.org/C2777511904","wikidata":"https://www.wikidata.org/wiki/Q425227","display_name":"Taxane","level":4,"score":0.7585395574569702},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.6974976062774658},{"id":"https://openalex.org/C2776802502","wikidata":"https://www.wikidata.org/wiki/Q417589","display_name":"Anthracycline","level":4,"score":0.6613015532493591},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6028441190719604},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5345966219902039},{"id":"https://openalex.org/C2780739268","wikidata":"https://www.wikidata.org/wiki/Q2112244","display_name":"Progression-free survival","level":3,"score":0.4709131419658661},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.45240479707717896},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4161393642425537},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.40347573161125183},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.39729517698287964},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.39013636112213135},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.3817789852619171},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.37643754482269287},{"id":"https://openalex.org/C2989005","wikidata":"https://www.wikidata.org/wiki/Q214963","display_name":"Nuclear medicine","level":1,"score":0.33720141649246216},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2014.32.15_suppl.1035","doi":"https://doi.org/10.1200/jco.2014.32.15_suppl.1035","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2014.32.15_suppl.1035","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2586862487","https://openalex.org/W2484150980","https://openalex.org/W2021264260","https://openalex.org/W2768302784","https://openalex.org/W2947350492","https://openalex.org/W2497067009","https://openalex.org/W2125913015","https://openalex.org/W2741748273","https://openalex.org/W2730443390","https://openalex.org/W3087151336"],"abstract_inverted_index":{"1035":[0],"Background:":[1],"RAM,":[2],"a":[3,22,136,169],"recombinant":[4],"human":[5],"IgG1":[6],"monoclonal":[7],"antibody,":[8],"targets":[9],"VEGFR-2":[10],"and":[11,18,73,95,109,115,120,158,177,183,198,211,224,230,241,268,282,291,316],"blocks":[12],"the":[13,40,79,144,181,321],"interaction":[14],"of":[15,31,42,139,174,204,251,280,301,311],"VEGF":[16],"ligands":[17],"VEGFR-2.":[19],"E":[20,45,54,89,162,184,227,257,293,304,333],"is":[21],"microtubule":[23],"inhibitor":[24],"active":[25],"in":[26,51,61,78,143,156,161,180,206,214,228,232,254,320],"MBC.":[27,65],"The":[28],"primary":[29],"goal":[30],"this":[32],"multicenter":[33],"US":[34],"study":[35],"was":[36,153,194,208,220],"to":[37,44,53,58,85,303],"identify":[38],"if":[39],"addition":[41],"RAM":[43,97,223,302],"would":[46],"increase":[47],"progression-free":[48],"survival":[49,172],"(PFS)":[50],"comparison":[52],"alone":[55],"as":[56],"third-":[57],"fifth-line":[59],"therapy":[60,108],"patients":[62],"(pts)":[63],"with":[64,68,135,168],"Methods:":[66],"Pts":[67],"locally":[69],"recurrent":[70],"or":[71,88],"MBC":[72],"2-4":[74],"prior":[75,106],"chemotherapy":[76],"regimens":[77],"advanced":[80],"setting":[81],"were":[82,124,130,142,318],"randomized":[83],"1:1":[84],"receive":[86],"RAM+E":[87,157,182,197,207,255,275,289,322,331],"(E":[90],"1.4":[91],"mg/m2":[92],"days":[93],"1":[94,283,292],"8;":[96],"10":[98,373,388],"mg/kg":[99],"day":[100],"1;":[101],"q21":[102],"days).":[103],"Stratifications":[104],"included":[105,258,277],"antiangiogenic":[107],"triple":[110],"negative":[111],"status.":[112],"Prior":[113],"anthracycline":[114],"taxane":[116],"treatment,":[117],"normal":[118],"LVEF,":[119],"ECOG":[121],"PS":[122],"0-1":[123],"required.":[125],"Treated,":[126],"stable":[127],"brain":[128],"metastases":[129],"allowed.":[131],"Results:":[132],"141":[133],"pts":[134,290],"median":[137,170],"age":[138],"56":[140],"yrs":[141],"ITT":[145],"population":[146],"(RAM+E,":[147],"n=71;":[148],"E,":[149],"n=70).":[150],"Median":[151,202],"PFS":[152],"4.4":[154],"mo":[155,160,176,179,210,213],"4.1":[159],"(HR=0.8:":[163,186],"95%":[164],"CI":[165],"0.6-1.2;":[166],"p=0.4)":[167],"overall":[171],"(OS)":[173],"13.5":[175],"11.5":[178],"arm":[185],"95%CI":[187],"0.5-1.3;":[188],"p=0.4),":[189],"respectively.":[190],"Objective":[191],"response":[192,205],"rate":[193],"20%":[195],"for":[196,200,222,226],"24%":[199],"E.":[201,215,233],"duration":[203],"5.5":[209],"3.0":[212],"Relative":[216],"mean":[217],"dose":[218],"intensity":[219],"95.3%":[221],"80.7%":[225],"RAM+E,":[229],"79.0%":[231],"All-cause":[234],"treatment":[235],"emergent":[236],"adverse":[237],"events":[238,279],"(TEAEs)":[239],"\u226520%":[240],"grade":[242,249,284,296,336,342],"3":[243,285,288,297,403,410],"\u22655%":[244],"are":[245],"shown":[246],"(Table).":[247],"Any":[248,335,341],"TEAEs":[250],"special":[252],"interest":[253],"vs.":[256,261,266,273],"bleeding":[259,276,317],"(18.8%":[260],"4.6%),":[262],"hypertension":[263],"(HTN)":[264],"(13%":[265],"1.5%),":[267],"congestive":[269],"heart":[270],"failure":[271],"(1.4%":[272],"0%).":[274],"7":[278,417],"epistaxis":[281],"GI":[286],"hemorrhage.":[287],"pt":[294],"had":[295],"HTN.":[298],"Conclusions:":[299],"Addition":[300],"did":[305],"not":[306],"improve":[307],"PFS.":[308],"Higher":[309],"rates":[310],"fatigue,":[312],"headache,":[313],"hypertension,":[314],"diarrhea,":[315],"observed":[319],"arm.":[323],"Clinical":[324],"trial":[325],"information:":[326],"NCT01427933.":[327],"TEAE,":[328],"n":[329],"(%)":[330],"(n=69)":[332],"(n=65)":[334],"(\u226520%)":[337,343],"Grade":[338,344],"\u22653":[339,345],"(\u22655%)":[340,346],"Fatigue":[347],"44":[348],"(64)":[349],"11":[350],"(16)":[351],"37":[352],"(57)":[353],"4":[354,399,413],"(6)":[355,400,414],"Neutropenia":[356],"29":[357,361],"(42)":[358,369],"27":[359,368,371],"(39)":[360,372],"(45)":[362],"24":[363],"(37)":[364],"Nausea":[365],"28":[366],"(41)":[367],"Headache":[370],"(15)":[374,389],"Constipation":[375],"20":[376],"(29)":[377,379],"19":[378,381],"Vomiting":[380],"(28)":[382],"17":[383,386],"(26)":[384],"Diarrhea":[385],"(25)":[387,402,409],"Dyspnea":[390],"15":[391,397],"(22)":[392,394,398],"14":[393,406],"Peripheral":[395],"neuropathy":[396],"16":[401,408],"(5)":[404,411],"Anemia":[405],"(20)":[407],"Leukopenia":[412],"8":[415],"(12)":[416],"(11)":[418]},"counts_by_year":[{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":9},{"year":2014,"cited_by_count":3}],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2017-04-07T00:00:00"}